|
1. |
Interaction of heterozygous βo‐thalassemia with single functional α‐globin gene |
|
American Journal of Hematology,
Volume 29,
Issue 2,
1988,
Page 63-66
Renzo Galanello,
Elisabetta Paglietti,
Maria A. Melis,
Maria G. Crobu,
Maria Addis,
Paolo Moi,
Antonio Cao,
Preview
|
PDF (376KB)
|
|
摘要:
AbstractIn this study, we analyzed the phenotypic manifestations resulting from the interaction of heterozygous βo‐thalassemia(βo‐39 nonsense mutation) with the functional loss of three α‐globin structural genes in six subjects, of whom four had the [‐αl–] α‐globin genotype and two the [–/αThα]α‐globin genotype. The β‐thalassemia defect was in all cases the nonsense mutation at codon 39. The nondeletion α‐thalassemia αthwas the initiation codon mutation (AUG→GUG) of the α‐2 gene. In all these subjects hypochromia and microcytosis were more marked than in βα ‐thalassemia heterozygotes with a full complement of four α‐globin genes. All but one had moderate anemia. The α:β globin chain synthesis ratios were consistently decreased. No cases had Hb H on electrophoresis. Subjects with [–/αThα] α‐globin genotype had more severe thalassemia‐like m
ISSN:0361-8609
DOI:10.1002/ajh.2830290202
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1988
数据来源: WILEY
|
2. |
Zinc status of children with sickle cell disease: Relationship to poor growth |
|
American Journal of Hematology,
Volume 29,
Issue 2,
1988,
Page 67-73
Carol K. Phebus,
Barbara J. Maciak,
Margaret F. Gloninger,
Harbajan S. Paul,
Preview
|
PDF (593KB)
|
|
摘要:
AbstractWe examined the zinc status of 80 children with sickle cell disease (SCD) and 44 disease‐free sibling controls aged 3 to 18 years. For both patients and controls, variations in serum zinc by age, type of hemoglobinopathy, and growth status were measured. The mean serum zinc concentration of patients was significantly lower than for controls (77.8 ± 9.9 vs. 82.2 ± 9.8 μg/dl, mean ± 1SD,P<.05). Serum levels of alkaline phosphatase (AP) and retinol‐binding protein (RBP), two zinc‐dependent proteins, were also lower among patients (AP: 171 ± 66 vs. 243 ± 97 IU/L,P<.001; RBP: 1.92 ± .9 vs. 2.77 ± .9 mg/dl,P<.001). Patients ≥ 12 years of age (n = 34) had significantly lower zinc levels than those<12 years (74.5 ± 8.4 vs. 80.3 ± 10.3 μg/dl,P<.01), and children with homozygous SCD (Hb SS, n = 55) had a more pronounced deficiency than those with a variant hemoglobinopathy (76.3 ± 8.9 vs. 81.5 ± 11.5, μg/dl,P<.05). Patients classified as having “poor” growth (height‐for‐age<5th percentile, n = 24) had a lower serum zinc level than those with “normal” growth (72.8 ± 8.0 vs. 79.8 ± 10.0 μg/dl,P<.01). Dietary intake data, body mass index, and serum total protein and albumin levels were similar for patients and controls, suggesting that zinc deficiency in SCD does not relate to inadequate dietary intake. The origin of low serum zinc levels in children with SCD is more likely to relate to factors such as increased urinary zinc excretion, chronic intravascular
ISSN:0361-8609
DOI:10.1002/ajh.2830290203
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1988
数据来源: WILEY
|
3. |
Permanent neurological complications in patients with thrombotic thrombocytopenic purpura |
|
American Journal of Hematology,
Volume 29,
Issue 2,
1988,
Page 74-78
Dina Ben‐Yehuda,
Michal Rose,
Yossef Michaeli,
Amiram Eldor,
Preview
|
PDF (422KB)
|
|
摘要:
AbstractAccording to previous clinical studies, the neurological manifestations observed in patients with thrombotic thrombocytopenic purpura (TTP) are considered to be transient. The introduction of plasma therapy in 1977 as major treatment modality for TTP has changed the prognosis of the disease. In a clinical survey of 38 patients with TTP who received plasma therapy, we have observed five patients who developed permanent neurological deficits despite their prompt recovery from TTP. In this study, we describe the new complication of TTP and summarize the neurological manifestations observed in these patients during their first episode of TTP and during the relapses, which occurred in 12 of them.
ISSN:0361-8609
DOI:10.1002/ajh.2830290204
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1988
数据来源: WILEY
|
4. |
Treatment of “poor risk” acute nonlymphocytic leukemia with continuously infused low‐dose cytosine arabinoside |
|
American Journal of Hematology,
Volume 29,
Issue 2,
1988,
Page 79-84
Edward P. Balaban,
John V. Cox,
Nancy R. Schneider,
Cheryl A. Harth,
Barbara B. Haley,
Richard Sheehan,
Eugene P. Frenkel,
Preview
|
PDF (430KB)
|
|
摘要:
AbstractThere is currently little experience using a continuous intravenous infusion of low‐dose cytosine arabinoside (LDARA‐C) in the treatment of acute nonlymphocytic leukemia (ANLL). We report the results in 12 patients with ANLL described as either relapsed ANLL, ANLL with a preceding myelodysplastic phase, or ANLL in the elderly treated with 14 days of continuous intravenous LDARA‐C (20 mg/m2/day). Complete responses (CR) were seen in five patients (42%) and partial responses (PR) in three patients (25%). Treatment resulted in overall and clonal cytoreduction, which was evident by serial bone marrow exams and bone marrow cytogenetic analysis. The ability to obtain a CR correlated with the finding of a low initial marrow cellularity (P<.05). This study finds that continuous intravenous infusion of LDARA‐C for ANLL can achieve response rates comparable to standard induction programs in a subset of patients traditionally defined as having a poor pr
ISSN:0361-8609
DOI:10.1002/ajh.2830290205
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1988
数据来源: WILEY
|
5. |
Association of large granular lymphocyte/natural killer cell proliferative disease and second hematologic malignancy |
|
American Journal of Hematology,
Volume 29,
Issue 2,
1988,
Page 85-93
Renato Bassan,
Alessandro Rambaldi,
Paola Allavena,
Mauro Abbate,
Basilio Marini,
Tiziano Barbui,
Preview
|
PDF (911KB)
|
|
摘要:
AbstractWe describe the first three patients with a large granular lymphocytosis/lymphocytic leukemia and another blood malignancy. In two, a myeloproliferative disorder developed soon after the diagnosis of abnormal proliferation of large granular lymphocytes‐natural killer (LGL‐NK) cells, a myelodysplastic syndrome evolving to acute leukemia and a Philadelphia‐positive chronic myelogenous leukemia. In these cases, LGLs expressed the phenotype of CD2 + NK and CD3 ‐ NK cells, respectively, and were clonal in the first patient as demonstrated by T‐cell receptor gene rearrangement study. In the third case, a similarly clonal excess of LGLs, phenotypically CD3 + NK cells, was detected following a diagnosis of B‐cell hairy‐cell leukemia. Clinically, the concurrence of LGL proliferation and other leukemia did not seem to confer a worse prognosis on the patients. Although an association by chance remains a possible explanation, a common origin from an altered precursor cell for both myeloid and LGL proliferations in the first two cases is discussed, whereas in the third it might be related to the severe immune derangement frequently observed in hairy
ISSN:0361-8609
DOI:10.1002/ajh.2830290206
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1988
数据来源: WILEY
|
6. |
Hematologic aspects of human immunodeficiency virus infection: Laboratory and clinical considerations |
|
American Journal of Hematology,
Volume 29,
Issue 2,
1988,
Page 94-105
Luke A. Perkocha,
George M. Rodgers,
Preview
|
PDF (1298KB)
|
|
摘要:
AbstractHematologic abnormalities are common in patients with HIV infection. This review will focus on HIV‐associated cytopenias and coagulation abnormalities. Their occurrence, laboratory evaluation, and clinical significance and the mechanisms underlying their development are discussed. Therapeutic modalities are presented, with an emphasis on treatment strategies for HIV‐associated thrombocytope
ISSN:0361-8609
DOI:10.1002/ajh.2830290207
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1988
数据来源: WILEY
|
7. |
Platelet antibody: Review of detection methods |
|
American Journal of Hematology,
Volume 29,
Issue 2,
1988,
Page 106-114
Kenneth A. Schwartz,
Preview
|
PDF (842KB)
|
|
摘要:
AbstractThe driving force behind development of in vitro methods for platelet antibodies is identification of plasma factors causing platelet destruction. Early methods relied on measurement of platelet activation. Current methods are more specific and use a purified antibody against immunoglobulin or complement, which is usually labeled with125I or tagged with an enzyme or fluorescein. Comparisons of guantitation of platelet‐associated IgG show wide variability between different methods. The disparate results can be related both to differences in binding of secondary antibodies to immunoglobulin in solution compared to immunoglobulins attached to platelets and to the improper assumption that the binding ratio between the secondary detecting and primary antiplatelet antibody is one. Most assays can 1) identify neonatal isoimmune thrombocytopenia and posttransfusion purpura, 2) help to differentiate between immune and nonimmune thrombocytopenias, 3) help to sort out the offending drug when drug‐induced thrombocytopenia is suspected, and 4) identify platelet alloantibodies and potential platelet donors via a cross match assay for refractory patients. However, the advantages of quantitative assays over qualitative methods with respect to predictions of patients clinical course and response to different treatments remain to be investiga
ISSN:0361-8609
DOI:10.1002/ajh.2830290208
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1988
数据来源: WILEY
|
8. |
Acute tumor lysis syndrome in non‐Hodgkin lymphoma induced by dexamethasone |
|
American Journal of Hematology,
Volume 29,
Issue 2,
1988,
Page 115-116
Kapil Dhingra,
Samuel R. Newcom,
Preview
|
PDF (132KB)
|
|
摘要:
AbstractAcute tumor lysis syndrome developed in a 30‐year‐old man with non‐Hodgkin lymphoma after dexamethasone administration. To the best of our knowledge this case is the first one reported following single agent corticosteroid trea
ISSN:0361-8609
DOI:10.1002/ajh.2830290209
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1988
数据来源: WILEY
|
9. |
An unusual case of extramedullary blast crisis in chronic myelocytic leukaemia |
|
American Journal of Hematology,
Volume 29,
Issue 2,
1988,
Page 117-119
Chi‐Shun Feng,
Preview
|
PDF (321KB)
|
|
摘要:
AbstractA 27‐year‐old man with chronic myelocytic leukaemia sustained two episodes of extramedullary blast transformation. The first episode was a lymphoblastic transformation in his cervical lymph nodes, which was treated and in remission for 15 months when a second blastic transformation occurred in the meninges. All the while, the bone marrow was free from blastic cri
ISSN:0361-8609
DOI:10.1002/ajh.2830290210
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1988
数据来源: WILEY
|
10. |
Transient ischemic attack in a patient with congenital protein‐c deficiency during treatment with stanozolol |
|
American Journal of Hematology,
Volume 29,
Issue 2,
1988,
Page 120-121
Valerio de Stefano,
Giuseppe Leone,
Luciana Teofili,
Rita Ferrelli,
Giuseppe Pollari,
Vincenzo Antonini,
Bruno Bizzi,
Preview
|
PDF (164KB)
|
|
摘要:
AbstractA patient with congenital protein‐C deficiency was treated with stanozolol for 8 weeks to increase circulating levels of protein C. A rise in protein C was achieved, accompanied by an increase in factor II, factor X, antithrombin III, and protein S; but at the 8th week the patient suffered a transient ischemia attac
ISSN:0361-8609
DOI:10.1002/ajh.2830290211
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1988
数据来源: WILEY
|
|